"Designing Growth Strategies is in our DNA"

Gastrointestinal Bleeding Treatment Market Size, Share & Industry Analysis, By Treatment Type (Proton Pump Inhibitors (PPIs), Vasoactive Drugs, Non-selective beta-blockers, Anticoagulant, and Others), By GI Tract Division (Upper and Lower), By Type (Acute and Chronic), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 30, 2026 | Format: PDF | Report ID: FBI115331

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Gastrointestinal Bleeding Disorder, By Key Regions
    2. Regulatory Scenario, By Key Countries/Regions
    3. New Product Launches, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  5. Global Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Octapharma AG
      2. Takeda Pharmaceutical Company Limited
      3. Novartis AG
      4. Mallinckrodt
      5. AstraZeneca
      6. CSL
      7. F. Hoffmann-La Roche Ltd
      8. Boehringer Ingelheim International GmbH
      9. Phathom Pharmaceuticals.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Gastrointestinal Bleeding Disorder, By Key Regions
    2. Regulatory Scenario, By Key Countries/Regions
    3. New Product Launches, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  5. Global Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Southeast Asia
      5. Australia
      6. Rest of Asia Pacific
  9. Latin America Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Treatment Type
      1. Proton Pump Inhibitors (PPIs)
      2. Vasoactive Drugs
      3. Non-selective beta-blockers
      4. Anticoagulant
      5. Others
    2. Market Analysis, Insights and Forecast – By GI Tract Division Division
      1. Upper
      2. Lower
    3. Market Analysis, Insights and Forecast – By Type
      1. Acute
      2. Chronic
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Octapharma AG
      2. Takeda Pharmaceutical Company Limited
      3. Novartis AG
      4. Mallinckrodt
      5. AstraZeneca
      6. CSL
      7. F. Hoffmann-La Roche Ltd
      8. Boehringer Ingelheim International GmbH
      9. Phathom Pharmaceuticals.
Read Less

Figure 1:  Global Gastrointestinal Bleeding Treatment Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025 & 2034

Figure 3:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025 & 2034

Figure 4:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025 & 2034

Figure 5:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 6:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 7:  Global Gastrointestinal Bleeding Treatment Market Value Share (%), by Region, 2025 & 2034

Figure 8:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by Treatment Type, 2025 & 2034

Figure 9:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025

Figure 10:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division, 2025 & 2034

Figure 11:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025

Figure 12:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by Type, 2025 & 2034

Figure 13:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025

Figure 14:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by Route of Administration, 2025 & 2034

Figure 15:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025

Figure 16:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 17:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 18:  North America Gastrointestinal Bleeding Treatment Market Value (USD million), by Country, 2025 & 2034

Figure 19:  North America Gastrointestinal Bleeding Treatment Market Value Share (%), by Country, 2025

Figure 20:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by Treatment Type, 2025 & 2034

Figure 21:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025

Figure 22:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division, 2025 & 2034

Figure 23:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025

Figure 24:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by Type, 2025 & 2034

Figure 25:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025

Figure 26:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by Route of Administration, 2025 & 2034

Figure 27:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025

Figure 28:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 29:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 30:  Europe Gastrointestinal Bleeding Treatment Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 31:  Europe Gastrointestinal Bleeding Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 32:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by Treatment Type, 2025 & 2034

Figure 33:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025

Figure 34:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division, 2025 & 2034

Figure 35:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025

Figure 36:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by Type, 2025 & 2034

Figure 37:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025

Figure 38:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by Route of Administration, 2025 & 2034

Figure 39:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025

Figure 40:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 41:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 42:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 43:  Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 44:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by Treatment Type, 2025 & 2034

Figure 45:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025

Figure 46:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division, 2025 & 2034

Figure 47:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025

Figure 48:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by Type, 2025 & 2034

Figure 49:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025

Figure 50:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by Route of Administration, 2025 & 2034

Figure 51:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025

Figure 52:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 53:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 54:  Latin America Gastrointestinal Bleeding Treatment Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 55:  Latin America Gastrointestinal Bleeding Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 56:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by Treatment Type, 2025 & 2034

Figure 57:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by Treatment Type, 2025

Figure 58:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division, 2025 & 2034

Figure 59:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division, 2025

Figure 60:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by GI Tract Division 2025 & 2034

Figure 61:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by GI Tract Division 2025

Figure 62:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by Type, 2025 & 2034

Figure 63:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by Type, 2025

Figure 64:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by Route of Administration, 2025 & 2034

Figure 65:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by Route of Administration, 2025

Figure 66:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 67:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 68:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 69:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share (%), by Country/ Sub-region, 2025

Figure 70:  Global Gastrointestinal Bleeding Treatment Market Share (%), by Company, 2025

Table 1:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 2:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 3:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 4:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 5:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 6:  Global Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Region, 2021-2034

Table 7:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 8:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 9:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 10:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 11:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 12:  North America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Country, 2021-2034

Table 13:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 14:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 15:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 16:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 17:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 18:  Europe Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034

Table 19:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 20:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 21:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 22:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 23:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 24:  Asia Pacific Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034

Table 25:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 26:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 27:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 28:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 29:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 30:  Latin America Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034

Table 31:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Treatment Type, 2021–2034

Table 32:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by GI Tract Division, 2021–2034

Table 33:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Type, 2021–2034

Table 34:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Route of Administration, 2021–2034

Table 35:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 36:  Middle East & Africa Gastrointestinal Bleeding Treatment Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034

Gastrointestinal Bleeding Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports